- Home
- HOWL vs VATE Comparison
HOWL vs VATE Comparison
Compare HOWL & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- VATE
- Stock Information
- Founded
- HOWL 2017
- VATE 1994
- Country
- HOWL United States
- VATE United States
- Employees
- HOWL N/A
- VATE N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- VATE Metal Fabrications
- Sector
- HOWL Health Care
- VATE Industrials
- Exchange
- HOWL Nasdaq
- VATE Nasdaq
- Market Cap
- HOWL 64.5M
- VATE 62.0M
- IPO Year
- HOWL 2021
- VATE 1996
- Fundamental
- Price
- HOWL $1.56
- VATE $5.26
- Analyst Decision
- HOWL Strong Buy
- VATE
- Analyst Count
- HOWL 5
- VATE 0
- Target Price
- HOWL $7.20
- VATE N/A
- AVG Volume (30 Days)
- HOWL 1.3M
- VATE 51.5K
- Earning Date
- HOWL 11-14-2025
- VATE 11-12-2025
- Dividend Yield
- HOWL N/A
- VATE N/A
- EPS Growth
- HOWL N/A
- VATE N/A
- EPS
- HOWL N/A
- VATE N/A
- Revenue
- HOWL N/A
- VATE $995,000,000.00
- Revenue This Year
- HOWL N/A
- VATE N/A
- Revenue Next Year
- HOWL N/A
- VATE N/A
- P/E Ratio
- HOWL N/A
- VATE N/A
- Revenue Growth
- HOWL N/A
- VATE N/A
- 52 Week Low
- HOWL $0.60
- VATE $3.71
- 52 Week High
- HOWL $2.96
- VATE $13.79
- Technical
- Relative Strength Index (RSI)
- HOWL 45.71
- VATE 57.21
- Support Level
- HOWL $1.55
- VATE $4.73
- Resistance Level
- HOWL $1.83
- VATE $5.67
- Average True Range (ATR)
- HOWL 0.13
- VATE 0.37
- MACD
- HOWL -0.03
- VATE 0.09
- Stochastic Oscillator
- HOWL 14.71
- VATE 73.72
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.